Antihypertensives, lipid regulators, antiplatelets and the oral antidiabetic range, including fixed-dose combinations.
The cardiovascular and metabolic range carries Finecure’s widest strength ladder, built for chronic-therapy prescribing where titration matters more than headline potency. Telmisartan combinations extend across amlodipine, chlorthalidone, hydrochlorothiazide and metoprolol; the antidiabetic range covers gliptins, gliflozins, biguanide combinations and alpha-glucosidase inhibitors. A defined subset is manufactured on oral solid dosage lines at a USFDA-inspected OSD site with an Establishment Inspection Report issued, and those products are marked individually rather than by category.
Our DSIR-approved R&D center continuously executes complex technology transfers and formulation development. If your required therapeutic is not listed in our active commercial matrix, contact our technical team to initiate a custom Contract Manufacturing (CDMO) project.
Submit CDMO / Tech-Transfer Inquiry
